OOIR: Observatory of International Research

Papers

(The H4-Index of Translational Psychiatry is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease	245
Mapping global prevalence of depression among postpartum women	239
Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review	192
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder	156
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease	139
Psycho-social factors associated with mental resilience in the Corona lockdown	134
Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence	113
Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders	110
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?	107
How machine-learning recommendations influence clinician treatment selections: the example of antidepressant selection	104
Depression, anxiety and associated factors among Chinese adolescents during the COVID-19 outbreak: a comparison of two cross-sectional studies	102
Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109)	89
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease	88
Mental disorders following COVID-19 and other epidemics: a systematic review and meta-analysis	87
A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches	84
Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress	84
Impact of COVID-19 lockdown on mental health in Germany: longitudinal observation of different mental health trajectories and protective factors	83
Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders	82
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial	76
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review	75
Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies	73
The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study	73
Machine learning for suicide risk prediction in children and adolescents with electronic health records	70
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression	70
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study	69

The effects of social isolation stress and discrimination on mental health	68
Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes	67
Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation	66
Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior	65
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium	65
Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings	64
Transdiagnostic dimensions of psychopathology explain individuals’ unique deviations from normative neurodevelopment in brain structure	63
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B	63
Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability	62
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents	60
A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder	60
Parental characteristics and offspring mental health and related outcomes: a systematic review of genetically informative literature	60
Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses	59
Early life adversity shapes neural circuit function during sensitive postnatal developmental periods	59
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors	59
Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys	58
“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder	58
Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment	58
Association between DNA methylation and ADHD symptoms from birth to school age: a prospective meta-analysis	56
Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis	56
Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19	56
Psychological and biological resilience modulates the effects of stress on epigenetic aging	56
Network analysis of depressive and anxiety symptoms in adolescents during the later stage of the COVID-19 pandemic	56
Fractionating autism based on neuroanatomical normative modeling	55
Personalized machine learning of depressed mood using wearables	55
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review	55
Spontaneous and deliberate creative cognition during and after psilocybin exposure	55
From mechanisms to markers: novel noninvasive EEG proxy markers of the neural excitation and inhibition system in humans	54
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia	53
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?	53
Mindfulness practice for protecting mental health during the COVID-19 pandemic	53
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression	53
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study	53
Network analysis of depressive symptoms in Hong Kong residents during the COVID-19 pandemic	53